Prestige Consumer Healthcare Inc.

PBHNYSE • USD
47.80 USD
↘ 1.66 (3.36%)AT CLOSE (03:59 PM EDT)
47.82
↗ 0.02 (0.03%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
47.82
↗ 0.02 (0.03%)
🔴Market: CLOSED

Prestige Consumer Healthcare Inc. (PBH) trades at $47.80 per share. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, PBH appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Oct 23, 2026.

Open?$48.96
High?$49.34
Low?$47.70
Prev. Close?$49.46
Volume?530.1K
Avg. Volume?617.2K
VWAP?$48.23
Rel. Volume?0.86x
Bid / Ask
Bid?$47.61 × 100
Ask?$61.26 × 100
Spread?$13.65
Midpoint?$54.44
Valuation & Ratios
Market Cap?2.3B
Shares Out?47.4M
Float?46.6M
Float %?98.5%
P/E Ratio?13.16
P/B Ratio?1.18
EPS?$3.63
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Employees
890
Market Cap
2.3B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2005-02-10
Address
660 WHITE PLAINS RD.
TARRYTOWN, NY 10591
Phone: (914) 524-6800
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
23
Momentum?
35
Short Sent.?
54
Piotroski F-Score?3/9Weak
Altman Z-Score?1.60Distress
Confidence?74%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?9.96%Elevated
Short Interest?4.6M
Days to Cover?6.6
Free Float46.6M
Avg Daily Volume703.8K
Settlement Date2026-09-30
Financial Health
Current Ratio?3.23Strong
Quick Ratio?1.99Adequate
Cash Ratio?0.58Adequate
Debt/Equity?1.06Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
89/100
P/E?
Peers
100
S&P
87
13.2CHEAP▾
P/B?
Peers
100
S&P
93
1.18CHEAP▾
P/S?
Peers
100
S&P
65
2.05CHEAP▾
P/FCF?
Peers
100
S&P
90
9.6CHEAP▾
EV/EBITDA?
Peers
100
S&P
62
13.1FAIR▾
EV/Sales?
Peers
100
S&P
49
3.81FAIR▾
Returns & Efficiency
ROE?
Peers
50
S&P
30
9.0%FAIR▾
ROA?
Peers
50
S&P
34
3.8%FAIR▾
Cash Flow & Enterprise
FCF?$235.4M
Enterprise Value?$4.2B
Fundamentals ratios updated end of day